Issue Archive
|
About Us
|
Contact Us
|
Subscribe
|
Editorial Board
|
Author Guidelines
|
About Haymarket Media
Home
News
Web Exclusives
Daily Oncology News
New Drug Products
ASH 2011
ASCO 2011
ONS Annual Congress 2011
ASH 2010
CE
CE Articles
mycme.com
Departments
Advisor Forum
Ask a Pharmacist
Case of the Month
Case Study
Communication Challenges
From CancerCare
Issues in Cancer Survivorship
Radiation and Your Patient
Reflections
Stat Consult
The Patient's Voice
The Total Patient
Issue Archive
Topics
Chemotherapy
Communication
End-of-Life Issues
Pain Management
Palliative Care
Radiology
Side-Effect Management
Survivorship
Women's Health
Cancer Types
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Chemotherapy Regimens
Clinical Trials
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
For Your Patient
Advocacy
CancerCare Fact Sheets
Cancer Support Groups
Financial Assistance
Finding Clinical Trials
Palliative Care and Hospice
Patient Information
The Total Nurse
General Medicine in Oncology
Slideshows
Supplements
Jobs
Tools & Links
RSS
|
Login
|
Register
ONA
>
Healthday Main
> Nursing Conference News
Nursing Conference News
clientId = "8D70113C"; newsFeed = "P"; category = "10"; newsType = "26"; numberReturn = "12"; landingUrl = "http://www.oncologynurseadvisor.com/healthday-article/section/1319/";
Web Exclusives
Psychosocial approach useful in managing cancer pain
Delicia Honen Yard
February 03, 2012
Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
Experimental agent slows progression of colorectal cancer
Delicia Honen Yard
February 02, 2012
The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
In HER2 breast cancer, lapatinib works better with trastuzumab than without
Delicia Honen Yard
February 01, 2012
Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
more »